Tag Archives: Cell Therapeutics Inc

Indecent Disclosure: The Press Release Balancing Act

Sometimes it’s tough for biotechs to figure out what, exactly, constitutes news. Yesterday, Cell Therapeutics Inc. issued a release stating the FDA had “concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on…

Share